| abstract |
The present invention provides an improved composition for transmucosal administration, i.e. rapid and efficient delivery of therapeutically active substances to obtain a rapid, effective, sustainable, predictable and consistent therapeutic effect. It relates to a composition that allows uptake. In particular, the composition is intended for buccal and / or sublingual delivery. The present invention is particularly suitable for administering therapeutically active substances that affect the central nervous system, and is even more suitable where rapid onset of this effect is desirable or beneficial. The present invention is also particularly suitable for administering low solubility base or acid forms of active substances. |